FAP and cancer: Kallikreins, DPPIV (dipeptidyl peptidase IV), FAP (fibroblast activation protein) and PEP (prolyl endopeptidase) serine proteases are all crucial players in cancer, emerging as clinical markers and prospective diagnostic targets [61].